Basic Science Review Section: Statin Therapy--Part II: Clinical Considerations for Cardiovascular Disease
Sadowitz et al.
VASC ENDOVASCULAR SURG 2010;44:421-433.
ABSTRACT
Effect of statin therapy on colorectal cancer
Bardou et al.
Gut 2010;0:gut.2009.190900v1-gut.2009.190900.
ABSTRACT
| FULL TEXT
Cardiovascular Risk-Estimation Systems in Primary Prevention: Do They Differ? Do They Make a Difference? Can We See the Future?
Cooney et al.
Circulation 2010;122:300-310.
FULL TEXT
High Pre-{beta}1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol
Sethi et al.
Clin. Chem. 2010;56:1128-1137.
ABSTRACT
| FULL TEXT
Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants
Ray et al.
Arch Intern Med 2010;170:1024-1031.
ABSTRACT
| FULL TEXT
Variation in the Net Benefit of Aggressive Cardiovascular Risk Factor Control Across the US Population of Patients With Diabetes Mellitus
Timbie et al.
Arch Intern Med 2010;170:1037-1044.
ABSTRACT
| FULL TEXT
Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy.
Jafri et al.
J Am Coll Cardiol 2010;55:2846-2854.
ABSTRACT
| FULL TEXT
A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome.
Waksman et al.
J Am Coll Cardiol 2010;55:2727-2735.
ABSTRACT
| FULL TEXT
Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol.
Bayturan et al.
J Am Coll Cardiol 2010;55:2736-2742.
ABSTRACT
| FULL TEXT
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction
Yeh et al.
NEJM 2010;362:2155-2165.
ABSTRACT
| FULL TEXT
Rosuvastatin is similarly effective for primary prevention of cardiovascular disease in women as in men
Leventhal and Michos
Evid. Based Med. 2010;15:74-75.
FULL TEXT
Early statin use is an independent predictor of long-term graft survival
Moreso et al.
NDT Plus 2010;3:ii26-ii31.
ABSTRACT
| FULL TEXT
Rethinking the Epidemiology of Acute Myocardial Infarction: Challenges and Opportunities
Yeh and Go
Arch Intern Med 2010;170:759-764.
ABSTRACT
| FULL TEXT
Statins in the Treatment of Heart Failure
van der Harst and de Boer
Circ Heart Fail 2010;3:462-464.
FULL TEXT
Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular Disease
Sadowitz et al.
VASC ENDOVASCULAR SURG 2010;44:241-251.
ABSTRACT
Modeling the 4D Study: Statins and Cardiovascular Outcomes in Long-Term Hemodialysis Patients with Diabetes
Chan et al.
CJASN 2010;5:856-866.
ABSTRACT
| FULL TEXT
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
Glynn et al.
ANN INTERN MED 2010;152:488-496.
ABSTRACT
| FULL TEXT
Clinical implications of inflammation for cardiovascular primary prevention
Libby and Crea
Eur Heart J 2010;31:777-783.
ABSTRACT
| FULL TEXT
Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: A Therapeutic Dilemma
Calderon et al.
Mayo Clin Proc. 2010;85:349-356.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein and Coronary Heart Disease: Current and Future Therapies
Natarajan et al.
J Am Coll Cardiol 2010;55:1283-1299.
ABSTRACT
| FULL TEXT
The Numbers Are In: Statins for the Primary Prevention of Cardiovascular Disease in Women
Duvernoy and Blumenthal
Circulation 2010;121:1063-1065.
FULL TEXT
Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia: Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women From Primary Prevention Trials
Mora et al.
Circulation 2010;121:1069-1077.
ABSTRACT
| FULL TEXT
Effect of Preoperative Statin Therapy on Patients Undergoing Isolated and Combined Valvular Heart Surgery.
Borger et al.
Ann. Thorac. Surg. 2010;89:773-780.
ABSTRACT
| FULL TEXT
A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women
Hamrefors et al.
J. Lipid Res. 2010;51:625-634.
ABSTRACT
| FULL TEXT
Adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins
Shroufi and Powles
J. Epidemiol. Community Health 2010;64:109-113.
ABSTRACT
| FULL TEXT
Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)
Everett et al.
Circulation 2010;121:143-150.
ABSTRACT
| FULL TEXT
Risk Factors in First Presentation Acute Coronary Syndromes (ACS): How Do We Move From Population to Individualized Risk Prediction?
Saab et al.
ANGIOLOGY 2009;60:663-667.
ABSTRACT
Cost Effectiveness and Screening Interval of Lipid Screening in Hodgkin's Lymphoma Survivors
Chen et al.
JCO 2009;27:5383-5389.
ABSTRACT
| FULL TEXT
Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein: Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)
Ridker et al.
Circ Cardiovasc Qual Outcomes 2009;2:616-623.
ABSTRACT
| FULL TEXT
Cardiovascular Benefit of Magnitude of Low-Density Lipoprotein Cholesterol Reduction: A Comparison of Subgroups by Age
Rahilly-Tierney et al.
Circulation 2009;120:1491-1497.
ABSTRACT
| FULL TEXT
Which is the best statin for the postoperative coronary artery bypass graft patient?
Conway and Musleh
Eur. J. Cardiothorac. Surg. 2009;36:628-632.
ABSTRACT
| FULL TEXT
High-density Lipoprotein Cholesterol: Current Perspective for Clinicians
Whayne
ANGIOLOGY 2009;60:644-649.
ABSTRACT
Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?
Connor and Tomson
BMJ 2009;339:b2949-b2949.
FULL TEXT
Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS)
Li et al.
J Clin Pharmacol 2009;49:947-956.
ABSTRACT
| FULL TEXT
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander et al.
JAMA 2009;302:49-57.
ABSTRACT
| FULL TEXT
The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study
Meaney et al.
J Clin Pharmacol 2009;49:838-847.
ABSTRACT
| FULL TEXT
Metabolic syndrome: intima-media thickness and beyond.
Golomb
J Am Coll Cardiol 2009;53:2280-2282.
FULL TEXT
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
Becker et al.
ANN INTERN MED 2009;150:830-839.
ABSTRACT
| FULL TEXT
Mendelian Randomization: Nature's Randomized Trial in the Post-Genome Era
Thanassoulis and O'Donnell
JAMA 2009;301:2386-2388.
FULL TEXT
Late Clinical Events After Drug-Eluting Stents: The Interplay Between Stent-Related and Natural History-Driven Events
Leon et al.
J Am Coll Cardiol Intv 2009;2:504-512.
ABSTRACT
| FULL TEXT
Effects of Statins on the Pharmacokinetics of Midazolam in Healthy Volunteers
Kokudai et al.
J Clin Pharmacol 2009;49:568-573.
ABSTRACT
| FULL TEXT
Statin Adherence and Risk of Accidents: A Cautionary Tale
Dormuth et al.
Circulation 2009;119:2051-2057.
ABSTRACT
| FULL TEXT
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
Karalis
Mayo Clin Proc. 2009;84:345-352.
ABSTRACT
| FULL TEXT
Management of Hyperlipidemia in Older Adults
Alexander et al.
J CARDIOVASC PHARMACOL THER 2009;14:49-58.
ABSTRACT
Carotid Intima-Media Thickness and Coronary Artery Calcium Score as Indications of Subclinical Atherosclerosis
Lester et al.
Mayo Clin Proc. 2009;84:229-233.
ABSTRACT
| FULL TEXT
Pravastatin for Cardiovascular Event Primary Prevention in Patients With Mild-to-Moderate Hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study
Kushiro et al.
Hypertension 2009;53:135-141.
ABSTRACT
| FULL TEXT
Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.
Robinson et al.
J Am Coll Cardiol 2009;53:316-322.
ABSTRACT
| FULL TEXT
Association Between Statin Use and Risk for Keratinocyte Carcinoma in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
Dore et al.
ANN INTERN MED 2009;150:9-18.
ABSTRACT
| FULL TEXT
JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?
SHISHEHBOR and HAZEN
Cleveland Clinic Journal of Medicine 2009;76:37-44.
ABSTRACT
| FULL TEXT
Associations Between Statin Treatment and Markers of Inflammation, Vasoconstriction, and Coagulation in Patients With Abdominal Aortic Aneurysm
Gottsater et al.
VASC ENDOVASCULAR SURG 2009;42:567-573.
ABSTRACT
Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?
Maher et al.
J. Leukoc. Biol. 2009;85:186-193.
ABSTRACT
| FULL TEXT
Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis: Insights From ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation)
Nicholls et al.
Circulation 2008;118:2506-2514.
ABSTRACT
| FULL TEXT
The Metabolic Syndrome
Cornier et al.
Endocr. Rev. 2008;29:777-822.
ABSTRACT
| FULL TEXT
Interaction between statins and clopidogrel: is there anything clinically relevant?
Bhindi et al.
QJM 2008;101:915-925.
ABSTRACT
| FULL TEXT
Primary Prevention and Statins: Is It Just About Going to Class?
Krasuski
Mayo Clin Proc. 2008;83:1313-1315.
FULL TEXT
Comparison of Cardiovascular Event Rates in Patients Without Cardiovascular Disease in Whom Atorvastatin or Simvastatin Was Newly Initiated
Jacobson et al.
Mayo Clin Proc. 2008;83:1316-1325.
ABSTRACT
| FULL TEXT
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments A Network Meta-Analysis Involving More Than 65,000 Patients.
Mills et al.
J Am Coll Cardiol 2008;52:1769-1781.
ABSTRACT
| FULL TEXT
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker et al.
NEJM 2008;359:2195-2207.
ABSTRACT
| FULL TEXT
Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients
Wiesbauer et al.
J. Am. Soc. Nephrol. 2008;19:2211-2218.
ABSTRACT
| FULL TEXT
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy and Yellon
Postgrad. Med. J. 2008;84:590-598.
ABSTRACT
| FULL TEXT
Is Red Yeast Rice a Suitable Alternative for Statins?-Reply-I
Becker et al.
Mayo Clin Proc. 2008;83:1294-1296.
FULL TEXT
Lipid-Lowering Therapy is Related to Inflammatory Markers and 3-Year Mortality in Patients With Critical Limb Ischemia
Isma et al.
ANGIOLOGY 2008;59:542-548.
ABSTRACT
Metabolism, Pharmacokinetics, and Excretion of a Cholesteryl Ester Transfer Protein Inhibitor, Torcetrapib, in Rats, Monkeys, and Mice: Characterization of Unusual and Novel Metabolites by High-Resolution Liquid Chromatography-Tandem Mass Spectrometry and 1H Nuclear Magnetic Resonance
Prakash et al.
Drug Metab. Dispos. 2008;36:2064-2079.
ABSTRACT
| FULL TEXT
Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline
Rosenzweig et al.
J. Clin. Endocrinol. Metab. 2008;93:3671-3689.
ABSTRACT
| FULL TEXT
Statins, Low-Density Lipoprotein Cholesterol, and Risk of Cancer
Alsheikh-Ali et al.
J Am Coll Cardiol 2008;52:1141-1147.
ABSTRACT
| FULL TEXT
Targeted versus global approaches to the management of hypercholesterolaemia
Reynolds et al.
The Journal of the Royal Society for the Promotion of Health 2008;128:248-254.
ABSTRACT
Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia
Steinberg et al.
Circulation 2008;118:672-677.
FULL TEXT
The Role of Statin Drugs in the Management of the Peripheral Vascular Patient
Samson
VASC ENDOVASCULAR SURG 2008;42:352-366.
ABSTRACT
A Practical 'ABCDE' Approach to the Metabolic Syndrome
Blaha et al.
Mayo Clin Proc. 2008;83:932-943.
ABSTRACT
| FULL TEXT
Do People With Diabetes Need Statins?
White
The Diabetes Educator 2008;34:664-673.
ABSTRACT
| FULL TEXT
The Parodox of Glycemic Control and Cardiovascular Complications: Sorting Out the Data
Dokken
Diabetes Spectr. 2008;21:150-152.
FULL TEXT
The Association of Testosterone Levels with Overall Sleep Quality, Sleep Architecture, and Sleep-Disordered Breathing
Barrett-Connor et al.
J. Clin. Endocrinol. Metab. 2008;93:2602-2609.
ABSTRACT
| FULL TEXT
Over-the-Counter Sales of Statins and Other Drugs for Asymptomatic Conditions
Tinetti
NEJM 2008;358:2728-2732.
FULL TEXT
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy and Yellon
Heart 2008;94:706-714.
ABSTRACT
| FULL TEXT
Almonds Reduce Biomarkers of Lipid Peroxidation in Older Hyperlipidemic Subjects
Jenkins et al.
J. Nutr. 2008;138:908-913.
ABSTRACT
| FULL TEXT
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial
Howard et al.
JAMA 2008;299:1678-1689.
ABSTRACT
| FULL TEXT
Primary prevention with pravastatin for 5 years continued to prevent coronary events in the next 10 years
Woodend
Evid. Based Nurs. 2008;11:52-52.
FULL TEXT
Letter Regarding Article by Leeper et al, "Statin Use in Patients With Extremely Low Low-Density Lipoprotein Levels Is Associated With Improved Survival"
Anderson and Salgado
Circulation 2008;117:e174-e174.
FULL TEXT
Applications of statins in cardiothoracic surgery: more than just lipid-lowering
Paraskevas
Eur. J. Cardiothorac. Surg. 2008;33:377-390.
ABSTRACT
| FULL TEXT
HDL-cholesterol modulation and its impact on the management of cardiovascular risk
Ferns and Keti
Ann Clin Biochem 2008;45:122-128.
ABSTRACT
| FULL TEXT
Lifestyle or Life-Saving Medicines? A Primary Healthcare Professional and Consumer Opinion Survey on Over-the-Counter Statins
Vamvakopoulos et al.
The Annals of Pharmacotherapy 2008;42:413-420.
ABSTRACT
| FULL TEXT
Statin Therapy for Stroke Prevention
Nassief and Marsh
Stroke 2008;39:1042-1048.
ABSTRACT
| FULL TEXT
Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required
Superko and King
Circulation 2008;117:560-568.
FULL TEXT
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study)
Mizuno et al.
Circulation 2008;117:494-502.
ABSTRACT
| FULL TEXT
Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis
Jenkins et al.
CMAJ 2008;178:157-164.
ABSTRACT
| FULL TEXT
Adolescent Overweight and Future Adult Coronary Heart Disease
Bibbins-Domingo et al.
NEJM 2007;357:2371-2379.
ABSTRACT
| FULL TEXT
Family practice patients' adherence to statin medications
Natarajan et al.
cfp 2007;53:2144-2145.
ABSTRACT
| FULL TEXT
Impact of Statins on Risk of Stroke: A Meta-Analysis
Henyan et al.
The Annals of Pharmacotherapy 2007;41:1937-1945.
ABSTRACT
| FULL TEXT
Primary Prevention of Coronary Artery Disease
Domanski
NEJM 2007;357:1543-1545.
FULL TEXT
Impact of C-reactive protein on treatment of patients with cardiovascular disease
Gortney and Sanders
Am J Health Syst Pharm 2007;64:2009-2016.
ABSTRACT
| FULL TEXT
Simvastatin Protects against Multiple Low-Dose Streptozotocin-Induced Type 1 Diabetes in CD-1 Mice and Recurrence of Disease in Nonobese Diabetic Mice
Rydgren et al.
J. Pharmacol. Exp. Ther. 2007;323:180-185.
ABSTRACT
| FULL TEXT
Preprocedural Statin Therapy in Percutaneous Coronary Intervention
Cahoon and Crouch
The Annals of Pharmacotherapy 2007;41:1687-1693.
ABSTRACT
| FULL TEXT
Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke
Colivicchi et al.
Stroke 2007;38:2652-2657.
ABSTRACT
| FULL TEXT
HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events
Barter et al.
NEJM 2007;357:1301-1310.
ABSTRACT
| FULL TEXT
Are patients with hyperlipidemia undertreated?: Study of patients admitted to hospital with coronary events
Lipson et al.
cfp 2007;53:1502-1507.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Singh et al.
JAMA 2007;298:786-798.
ABSTRACT
| FULL TEXT